2015-2025 Global Prescription Dermatological Drugs Market Research by Type, End-Use and Region (COVID-19 Version)

July 2020 | 99 pages | ID: 2744C5FDF8E5EN
99Strategy

Abstracts

SUMMARY

The global Prescription Dermatological Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

• Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
• Chapter 2: Global Production & Consumption Market by Type and End-Use
• Chapter 3: Europe Production & Consumption Market by Type and End-Use
• Chapter 4: America Production & Consumption Market by Type and End-Use
• Chapter 5: Asia Production & Consumption Market by Type and End-Use
• Chapter 6: Oceania Production & Consumption Market by Type and End-Use
• Chapter 7: Africa Production & Consumption Market by Type and End-Use
• Chapter 8: Global Market Forecast by Type, End-Use and Region
• Chapter 9: Company information, Sales, Cost, Margin, news etc.
• Chapter 10: Market Competition by Companies and Market Concentration Ratio
• Chapter 11: Market Impact by Coronavirus.
• Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

• Johnson & Johnson
• Merck
• Bayer
• Mylan Pharmaceuticals
• Pfizer
• F. Hoffmann-La Roche
• Allergan
• Valeant Pharmaceuticals
• PharmaDerm Pharmaceuticals
• Allergan Inamed Corporation

Key Types

• Anti-acne Drugs
• Anti-aging Drugs
• Dermatitis Drugs
• Hair Loss Drugs
• Psoriasis Drugs
• Skin Cancer Drugs
• Melasma Drugs
• Seborrhea Drugs

Key End-Use

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report can be dispatched within 24-48 Hours.

Contents

CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Prescription Dermatological Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Prescription Dermatological Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Prescription Dermatological Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Prescription Dermatological Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Prescription Dermatological Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaPrescription Dermatological Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Prescription Dermatological Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Prescription Dermatological Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Prescription Dermatological Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Prescription Dermatological Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Table Global Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Table America Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Prescription Dermatological Drugs Production Forecast
Figure Global Prescription Dermatological Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Prescription Dermatological Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Prescription Dermatological Drugs Forecast by Type
Table Global Prescription Dermatological Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global Prescription Dermatological Drugs Revenue Share by Type in 2025 (Million USD)
Table Global Prescription Dermatological Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global Prescription Dermatological Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global Prescription Dermatological Drugs Forecast by End-Use (2020E-2025F)
Table Global Prescription Dermatological Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Prescription Dermatological Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Prescription Dermatological Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Prescription Dermatological Drugs Forecast by Region (2020E-2025F)
Table Global Prescription Dermatological Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Prescription Dermatological Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global Prescription Dermatological Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Prescription Dermatological Drugs Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Johnson & Johnson
  9.1.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
  9.1.2 Johnson & Johnson Products & Services
  9.1.3 Johnson & Johnson Company Dynamics & News
  9.1.4 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Merck
  9.2.1 Merck Profile
Table Merck Overview List
  9.2.2 Merck Products & Services
  9.2.3 Merck Company Dynamics & News
  9.2.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Bayer
  9.3.1 Bayer Profile
Table Bayer Overview List
  9.3.2 Bayer Products & Services
  9.3.3 Bayer Company Dynamics & News
  9.3.4 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Mylan Pharmaceuticals
  9.4.1 Mylan Pharmaceuticals Profile
Table Mylan Pharmaceuticals Overview List
  9.4.2 Mylan Pharmaceuticals Products & Services
  9.4.3 Mylan Pharmaceuticals Company Dynamics & News
  9.4.4 Mylan Pharmaceuticals Business Operation Conditions
Table Business Operation of Mylan Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Pfizer
  9.5.1 Pfizer Profile
Table Pfizer Overview List
  9.5.2 Pfizer Products & Services
  9.5.3 Pfizer Company Dynamics & News
  9.5.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 F. Hoffmann-La Roche
  9.6.1 F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Overview List
  9.6.2 F. Hoffmann-La Roche Products & Services
  9.6.3 F. Hoffmann-La Roche Company Dynamics & News
  9.6.4 F. Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Allergan
  9.7.1 Allergan Profile
Table Allergan Overview List
  9.7.2 Allergan Products & Services
  9.7.3 Allergan Company Dynamics & News
  9.7.4 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Valeant Pharmaceuticals
  9.8.1 Valeant Pharmaceuticals Profile
Table Valeant Pharmaceuticals Overview List
  9.8.2 Valeant Pharmaceuticals Products & Services
  9.8.3 Valeant Pharmaceuticals Company Dynamics & News
  9.8.4 Valeant Pharmaceuticals Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 PharmaDerm Pharmaceuticals
  9.9.1 PharmaDerm Pharmaceuticals Profile
Table PharmaDerm Pharmaceuticals Overview List
  9.9.2 PharmaDerm Pharmaceuticals Products & Services
  9.9.3 PharmaDerm Pharmaceuticals Company Dynamics & News
  9.9.4 PharmaDerm Pharmaceuticals Business Operation Conditions
Table Business Operation of PharmaDerm Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Allergan Inamed Corporation
  9.10.1 Allergan Inamed Corporation Profile
Table Allergan Inamed Corporation Overview List
  9.10.2 Allergan Inamed Corporation Products & Services
  9.10.3 Allergan Inamed Corporation Company Dynamics & News
  9.10.4 Allergan Inamed Corporation Business Operation Conditions
Table Business Operation of Allergan Inamed Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Prescription Dermatological Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Prescription Dermatological Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Prescription Dermatological Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Prescription Dermatological Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Prescription Dermatological Drugs Market Concentration Ratio in 2020E
Figure America Prescription Dermatological Drugs Market Concentration Ratio in 2020E
Figure Asia Prescription Dermatological Drugs Market Concentration Ratio in 2020E
Figure Oceania Prescription Dermatological Drugs Market Concentration Ratio in 2020E
Figure Africa Prescription Dermatological Drugs Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON PRESCRIPTION DERMATOLOGICAL DRUGS INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 PRESCRIPTION DERMATOLOGICAL DRUGS INDUSTRY SUMMARY & CONCLUSION

List Of Tables

LIST OF TABLES
Table Global Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Table America Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Table America Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Prescription Dermatological Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Prescription Dermatological Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Prescription Dermatological Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa Prescription Dermatological Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa Prescription Dermatological Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Prescription Dermatological Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Prescription Dermatological Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Prescription Dermatological Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global Prescription Dermatological Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global Prescription Dermatological Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global Prescription Dermatological Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Prescription Dermatological Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Prescription Dermatological Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Prescription Dermatological Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Johnson & Johnson  Overview List
Table Business Operation of Johnson & Johnson  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck  Overview List
Table Business Operation of Merck  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer  Overview List
Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Pharmaceuticals  Overview List
Table Business Operation of Mylan Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer  Overview List
Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche  Overview List
Table Business Operation of F. Hoffmann-La Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan  Overview List
Table Business Operation of Allergan  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals  Overview List
Table Business Operation of Valeant Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PharmaDerm Pharmaceuticals  Overview List
Table Business Operation of PharmaDerm Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Inamed Corporation  Overview List
Table Business Operation of Allergan Inamed Corporation  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Prescription Dermatological Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Prescription Dermatological Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Prescription Dermatological Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Prescription Dermatological Drugs Sales Volume Share by Companies, 2015-2020E (Volume)

List Of Figures

LIST OF FIGURES
Figure Europe Prescription Dermatological Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Prescription Dermatological Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Prescription Dermatological Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Prescription Dermatological Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Prescription Dermatological Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaPrescription Dermatological Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Prescription Dermatological Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Prescription Dermatological Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Prescription Dermatological Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Prescription Dermatological Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Figure Global Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
Figure Global Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Figure Europe Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
Figure Europe Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Figure America Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
Figure America Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Figure Asia Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
Figure Asia Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Figure Oceania Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
Figure Oceania Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Prescription Dermatological Drugs Revenue Share by Type in 2020 (Million USD)
Figure Africa Prescription Dermatological Drugs Production Volume Share by Type in 2020 (Volume)
Figure Africa Prescription Dermatological Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Prescription Dermatological Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Prescription Dermatological Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Prescription Dermatological Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Prescription Dermatological Drugs Revenue Share by Type in 2025 (Million USD)
Figure Global Prescription Dermatological Drugs Production Volume Share by Type in 2025 (Volume)
Figure Global Prescription Dermatological Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Prescription Dermatological Drugs Consumption Value Share by Region in 2025 (Million USD)
Figure Global Prescription Dermatological Drugs Consumption Volume Share by Region in 2025 (Volume)